| Financial Year |
March 31 2023 |
| Monetary Funds |
6,891,771,920.12 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
219,018,770.80 |
| Accounts Receivable |
4,110,913,352.48 |
| Advances to Suppliers |
166,028,842.92 |
| Other Receivables |
1,364,740,438.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
769,071,284.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
56,310,780.03 |
| Total Current Assets |
13,947,004,834.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
435,948,304.55 |
| Investment Properties |
608,136,786.05 |
| Fixed Assetes |
1,939,731,444.91 |
| Under-construction Projects |
288,064,464.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
620,715,650.16 |
| R&D expenses |
-- |
| Goodwill |
146,685,258.04 |
| Long-Term Deferred and Prepaid Expenses |
89,161,624.04 |
| Deferred Income Tax Assets |
102,346,667.64 |
| Other Non-Current Assets |
849,173,563.07 |
| Sub-Total of Non-Current Assets |
5,242,855,503.14 |
| Total Assets |
19,189,860,338.12 |
| Short-Term Loans |
5,482,136,815.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,618,769,133.23 |
| Accounts Payable |
2,357,850,063.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,651,218.65 |
| Taxes Payable |
44,993,017.82 |
| Interest Payable |
-- |
| Dividend Payable |
67,090,528.42 |
| Other payables |
691,810,885.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,132,616.23 |
| Other Current Liabilities |
71,894,962.30 |
| Sub-Total of Current Liabilities |
13,331,769,405.57 |
| Long-term Loans |
24,900,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
38,422,706.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,217,523.17 |
| Total Liabilities |
13,399,986,928.74 |
| Paid-In Capital(Or Share Stock) |
1,504,710,471.00 |
| Capital Surplus |
3,708,693,195.64 |
| Surplus Reserve |
152,771,843.59 |
| LESS:Treasury Stock |
230,651,529.31 |
| Undistributed Profits |
301,506,055.82 |
| Minority Stockholder's Interest |
352,843,372.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,437,030,036.74 |
| Owner's Equity（Stockholder's Equity） |
5,789,873,409.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,189,860,338.12 |
